Could cannabis provide relief for certain neurological diseases? Researchers continue to explore the possibilities, with numerous studies underway to examine efficacy and safety. For those diseases in which cannabis has shown some benefit, there are still barriers to optimizing therapy. You will hear from experts in cannabis and the management of neurologic conditions. They’ll share current data and considerations for practical cannabis use to treat symptoms associated with common neurological disorders.
At the completion of this knowledge-based activity, participants will be able to:
- Identify the components of cannabis that may be useful in the treatment of neurological disorders and explore their potential mechanisms of action.
- Identify neurological disorders in which the usage of cannabis may be beneficial for patients.
- Demonstrate proper communication about the usage, benefits, drawbacks, and adverse effects of cannabis in patients with neurological disorders.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-029-H01-P
To obtain credit for The Cannabis Connection: Exploring New Treatments for Neurological Disorders, participants will need to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: March 13, 2021
Expiration date: March 13, 2024 - No credit granted after this date
The Cannabis Connection: Exploring New Treatments for Neurological Disorders is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2021 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-21-029-H01-P||0.15 CEUs||March 13, 2021 - March 13, 2024|